131 related articles for article (PubMed ID: 1203891)
1. Action of Cis-dichlorodiammineplatinum(II) (NSC-119875) at ehe cellular level.
Drewinko B; Gottlieb JA
Cancer Chemother Rep; 1975; 59(3):665-73. PubMed ID: 1203891
[TBL] [Abstract][Full Text] [Related]
2. Effects of cis-dichlorodiammineplatinum(II) on human colon carcinoma cells in vitro.
Bergerat JP; Barlogie B; Drewinko B
Cancer Res; 1979 Apr; 39(4):1334-8. PubMed ID: 421217
[TBL] [Abstract][Full Text] [Related]
3. Synergistic cell inactivation by cis-dichlorodiammineplatinum in combination with 1-propargyl-5-chloropyrimidin-2-one.
Dornish JM; Pettersen EO; Oftebro R
Br J Cancer; 1987 Sep; 56(3):273-8. PubMed ID: 3663475
[TBL] [Abstract][Full Text] [Related]
4. Synergistic lethal effect of cis-dichlorodiammineplatinum and 1-beta-D-arabinofuranosylcytosine.
Bergerat JP; Drewinko B; Corry P; Barlogie B; Ho DH
Cancer Res; 1981 Jan; 41(1):25-30. PubMed ID: 7192598
[TBL] [Abstract][Full Text] [Related]
5. Combination chemotherapy in vitro with cis-dichlorodiammineplatinum(II).
Drewinko B; Green C; Loo TL
Cancer Treat Rep; 1976 Nov; 60(11):1619-25. PubMed ID: 1021234
[TBL] [Abstract][Full Text] [Related]
6. In vitro cytokinetic response of human colon cancer cells to cis-dichlorodiammineplatinum(II).
Bergerat JP; Barlogie B; Göhde W; Johnston DA; Drewinko B
Cancer Res; 1979 Nov; 39(11):4356-63. PubMed ID: 498069
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of cis-dichlorodiammineplatinum (II)-induced cytotoxicity by methylglyoxal.
Dornish JM; Pettersen EO
Anticancer Res; 1989; 9(4):1137-42. PubMed ID: 2817795
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in combination with cyclophosphamide (NSC-26271) in the treatment of human malignancies.
Piel IJ; Perlia CP
Cancer Chemother Rep; 1975; 59(5):995-9. PubMed ID: 1106849
[TBL] [Abstract][Full Text] [Related]
9. Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin-induced DNA interstrand cross-links and cytotoxicity in human glioblastoma cells.
Ali-Osman F; Berger MS; Rajagopal S; Spence A; Livingston RB
Cancer Res; 1993 Dec; 53(23):5663-8. PubMed ID: 8242621
[TBL] [Abstract][Full Text] [Related]
10. Kinetics and mechanism of the 1-beta-D-arabinofuranosylcytosine-induced potentiation of cis-diamminedichloroplatinum(II) cytotoxicity.
Vadi H; Drewinko B
Cancer Res; 1986 Mar; 46(3):1105-9. PubMed ID: 3080232
[TBL] [Abstract][Full Text] [Related]
11. Reduction of cis-dichlorodiammineplatinum-induced cell inactivation by benzaldehyde.
Dornish JM; Pettersen EO; Oftebro R; Melvik JE
Eur J Cancer Clin Oncol; 1984 Oct; 20(10):1287-93. PubMed ID: 6541584
[TBL] [Abstract][Full Text] [Related]
12. Modulation of cis-dichlorodiammineplatinum(II)-induced cytotoxicity by benzaldehyde derivatives.
Dornish JM; Pettersen EO
Cancer Lett; 1989 Jul; 46(1):63-8. PubMed ID: 2736510
[TBL] [Abstract][Full Text] [Related]
13. Effect of cis-dichlorodiammineplatinum(II) on cloned ovarian adenocarcinoma cells of the rat in vitro.
Sekiya S; Iwasawa H; Yamauchi K; Kubota K; Takamizawa H
Gynecol Oncol; 1981 Aug; 12(1):14-22. PubMed ID: 7196860
[No Abstract] [Full Text] [Related]
14. Selective inhibition of the nephrotoxicity of cis-dichlorodiammineplatinum(II) by WR-2721 without altering its antitumor properties.
Yuhas JM; Culo F
Cancer Treat Rep; 1980 Jan; 64(1):57-64. PubMed ID: 6247064
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of cis-dichlorodiammineplatinum(II).
Zwelling LA; Kohn KW
Cancer Treat Rep; 1979; 63(9-10):1439-44. PubMed ID: 387221
[TBL] [Abstract][Full Text] [Related]
16. The effect of cis-diamminedichloroplatinum (II) on cultured human lymphoma cells and its therapeutic implications.
Drewinko B; Brown BW; Gottlieb JA
Cancer Res; 1973 Dec; 33(12):3091-5. PubMed ID: 4760525
[No Abstract] [Full Text] [Related]
17. Combination effects of cis-dichlorodiammineplatinum with selected metahalones, pyrimidine sulfoxides and pyrimidine sulfones on human NHIK 3025 cells in vitro.
Dornish JM; Undheim K; Pettersen EO; Oftebro R; Laland SG
Anticancer Drug Des; 1988 Dec; 3(3):191-8. PubMed ID: 3207466
[TBL] [Abstract][Full Text] [Related]
18. Collateral resistance or sensitivity of human larynx carcinoma HEp2 cells resistant to cis-dichlorodiammineplatinum (II) or vincristine sulfate.
Osmak M
Neoplasma; 1992; 39(3):197-202. PubMed ID: 1528326
[TBL] [Abstract][Full Text] [Related]
19. Studies on cis-dichlorodiammineplatinum (II) as a radiosensitizer.
Alvarez MV; Cobreros G; Heras A; Lopez Zumel MC
Br J Cancer Suppl; 1978 Jun; 3():68-72. PubMed ID: 277260
[TBL] [Abstract][Full Text] [Related]
20. Cellular replication kinetics and persistence of sister chromatid exchange-inducing lesions in normal and lymphoma AKR cells following exposure to 1,3-bis(2-chloroethyl)-1-nitrosourea.
Biegel JA; Conner MK; Boggs SS
Cancer Res; 1982 Jul; 42(7):2816-20. PubMed ID: 7083172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]